Australia has already spent hundreds of millions over the past 36 months after raising the prices of 950 PBS medicines in 2022 to secure supply in a challenging global environment. If global pressure now forces higher prices for other medicines, so be it, but of course, it would be just another stop-gap solution for a system built on a terrible patient-loathing law.
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Podcast - Week in review
August 7, 2026 - - Podcast -
argenx partners with Monash University and Myostellar to develop muscular therapies
August 7, 2026 - - Latest News -
A new generation is rewriting their lives living with Cystic Fibrosis
August 7, 2026 - - Latest News -
US approves Moderna's mRNA flu vaccine in major technology milestone
August 7, 2026 - - Latest News -
If Australian companies shun their domestic market, who can blame multinationals?
August 6, 2026 - - Latest News -
Neuren reports record DAYBUE sales as royalties rise and global expansion nears
August 6, 2026 - - Australian Biotech -
Moderna begins Phase 1 trial of vaccine candidate against Bundibugyo Ebola Virus
August 6, 2026 - - Latest News

